Anglo-Swedish drugs giant AstraZeneca has tapped the bond market with an issue of notes in two tranches.
The group has successfully issued $1bn of 7-year fixed rate notes with a coupon of 1.95% and $1bn of 30-year fixed rate notes with a coupon of 4%.
The proceeds of the issue will be used for debt refinancing and general corporate purposes.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
JH
-
Shein shifts IPO focus to Hong KongThe development piles fresh pressure on London’s beleaguered stock market, which many had hoped would be boosted by Shein’s IPO
-
Scientists turn lead into gold – could it wreck the yellow metal's price?Medieval alchemists have been vindicated after scientists turned lead into gold, but the results aren’t going to crash the gold price any time soon
